Literature DB >> 6061751

Hemoglobin Yakina. I. Clinical and biochemical studies.

R T Jones, E E Osgood, B Brimhall, R D Koler.   

Abstract

Three members of a family who have erythrocytosis and a new hemoglobin, designated hemoglobin Yakima, are described. The abnormal hemoglobin is characterized by the substitution of histidine for aspartic acid at residue 99 in the beta-chain. Of three possible structure-function relations which would account for the increased oxygen affinity of hemoglobin Yakima, only two seem likely. These are: (a) an intrachain shift in the normal relations between the F and G helices and the heme group, or (b) an effect of the substituted side chain at a region of contact between nonpolar residues of the alpha- and beta-chains which favors the oxyhemoglobin quarternary structure.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6061751      PMCID: PMC292934          DOI: 10.1172/JCI105674

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  The structure of human hemoglobin. II. The separation and amino acid composition of the tryptic peptides from the alpha and beta chains.

Authors:  G GUIDOTTI; R J HILL; W KONIGSBERG
Journal:  J Biol Chem       Date:  1962-07       Impact factor: 5.157

2.  On the recombination of canine and human haemoglobins.

Authors:  E R HUEHNS; E M SHOOTER; G H BEAVEN
Journal:  J Mol Biol       Date:  1962-05       Impact factor: 5.469

3.  Familial occurrence of polycythemia and leukemia.

Authors:  J H LAWRENCE; A T GOETSCH
Journal:  Calif Med       Date:  1950-10

4.  Red blood cell survival in patients with aortic valvular disease and ball-valve prostheses.

Authors:  M T Brodeur; D W Sutherland; R D Koler; A Starr; J A Kimsey; H E Griswold
Journal:  Circulation       Date:  1965-10       Impact factor: 29.690

5.  Studies on the heterogeneity of hemoglobin. IX. The use of Tris(hydroxymethyl)aminomethanehcl buffers in the anion-exchange chromatography of hemoglobins.

Authors:  T H Huisman; A M Dozy
Journal:  J Chromatogr       Date:  1965-07

6.  Subunit exchange and ligand binding. II. The mechanism of the allosteric effect in hemoglobin.

Authors:  R Benesch; R E Benesch; I Tyuma
Journal:  Proc Natl Acad Sci U S A       Date:  1966-10       Impact factor: 11.205

7.  Benign familial erythrocytosis. Report of three cases and a review of the literature.

Authors:  P A Cassileth; G A Hyman
Journal:  Am J Med Sci       Date:  1966-06       Impact factor: 2.378

8.  Polycythemia associated with a hemoglobinopathy.

Authors:  S Charache; D J Weatherall; J B Clegg
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

9.  An improved method for the characterization of human haemoglobin mutants: identification of alpha-2-beta-2-95GLU, haemoglobin N (Baltimore).

Authors:  J B Clegg; M A Naughton; D J Weatherall
Journal:  Nature       Date:  1965-08-28       Impact factor: 49.962

10.  Hemoglobin Yakina. II. High blood oxygen affinity associated with compensatory erythrocytosis and normal hemodynamics.

Authors:  M J Novy; M J Edwards; J Metcalfe
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

View more
  17 in total

1.  Structure-function relations of human hemoglobins.

Authors:  Alain J Marengo-Rowe
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-07

2.  Hemoglobin Malmö Beta-97 (FG-4) histidine--glutamine: a cause of polycythemia.

Authors:  S H Boyer; S Charache; V F Fairbanks; J E Maldonado; A Noyes; E E Gayle
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

3.  Hemoglobin Yoshizuka (G10(108)beta asparagine--aspartic acid): a new variant with a reduced oxygen affinity from a Japanese family.

Authors:  T Imamura; S Fujita; Y Ohta; M Hanada; T Yanase
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

4.  Hemoglobin variants.

Authors:  T B Bradley
Journal:  Calif Med       Date:  1970-01

5.  Hemoglobin Hiroshima (beta-143 histidine--aspartic acid): a newly identified fast moving beta chain variant associated with increased oxygen affinity and compensatory erythremia.

Authors:  H B Hamilton; I Iuchi; T Miyaji; S Shibata
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

6.  Subunit dissociation of certain abnormal human hemoglobins.

Authors:  H F Bunn
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

7.  Hemoglobin Yakina. II. High blood oxygen affinity associated with compensatory erythrocytosis and normal hemodynamics.

Authors:  M J Novy; M J Edwards; J Metcalfe
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

8.  Hemoglobin olympia ( 20 valine leads to methionine): an electrophoretically silent variant associated with high oxygen affinity and erythrocytosis.

Authors:  G Stamatoyannopoulos; P E Nute; J W Adamson; A J Bellingham; D Funk
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Hemoglobinopathic erythrocytosis due to a new electrophoretically silent variant, hemoglobin San Diego (beta109 (G11)val--met).

Authors:  P E Nute; G Stamatoyannopoulos; M A Hermodson; D Roth
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  Hemoglobin brigham (alpha2Abeta2100 Pro--Leu). Hemoglobin variant associated with familial erythrocytosis.

Authors:  J J Lokich; W C Moloney; H F Bunn; S M Bruckheimer; H M Ranney
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.